Syndicated Research Studies

Controlled Release Drug Delivery Market Summary The global controlled release drug delivery market was valued at USD 59.8 billion in 2024 and is forecast to reach USD 148.6 billion by 2033, expanding at a CAGR of 10.7% from 2025 to 2033. Market growth is largely driven by shifting prescription preferences among physicians, who increasingly favor controlled-release systems over conventional drug delivery methods. This preference stems from the advantages these systems offer, including enhanced therapeutic effectiveness, improved patient adherence, and reduced overall treatment costs. Operating within a highly competitive and fragmented landscape, pharmaceutical companies are continuously adapting to evolving market demands. As a result, significant investments are being directed toward the development of advanced controlled-release drug delivery technologies. These ongoing efforts to improve drug performance and patient outcomes are playing a pivotal role in strengthening market dema...

Controlled Release Drug Delivery Market Growth & Trends The global  controlled release drug delivery market  size is estimated to reach USD 110.13 billion by 2030, registering a CAGR of 10.5%, according to a new report by Grand View Research, Inc. The benefits associated with controlled release drug delivery systems such as increased therapeutic efficacy, fewer side effects, and low treatment cost are the factors driving the growth of the market during the forecast period. These technologies offer various benefits over traditional delivery forms. Reduced dosage and dosage frequency, enhanced patient compliance, less gastrointestinal side effects, uniform drug effect, improved drug efficacy and safety, and reduced fluctuation of plasma drug levels are some of the major advantages offered by controlled release technology.  Controlled Release Drug Delivery Market Segmentation Grand View Research has segmented the global controlled release drug delivery market on the ...